IL55774A - Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture - Google Patents

Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture

Info

Publication number
IL55774A
IL55774A IL55774A IL5577478A IL55774A IL 55774 A IL55774 A IL 55774A IL 55774 A IL55774 A IL 55774A IL 5577478 A IL5577478 A IL 5577478A IL 55774 A IL55774 A IL 55774A
Authority
IL
Israel
Prior art keywords
derivatives
manufacture
certain
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL55774A
Other languages
English (en)
Other versions
IL55774A0 (en
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH546678A external-priority patent/CH639846A5/de
Priority claimed from CH546578A external-priority patent/CH642944A5/de
Priority claimed from CH940778A external-priority patent/CH644850A5/de
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Publication of IL55774A0 publication Critical patent/IL55774A0/xx
Publication of IL55774A publication Critical patent/IL55774A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IL55774A 1977-10-28 1978-10-20 Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture IL55774A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
LU78407 1977-10-28
LU78408 1977-10-28
CH546678A CH639846A5 (en) 1978-05-19 1978-05-19 Pharmaceutical preparations having antiandrogenic action, containing urea derivatives or hydantoin derivatives
CH546578A CH642944A5 (en) 1978-05-19 1978-05-19 Urea derivatives
CH940778A CH644850A5 (en) 1977-10-28 1978-09-07 Pharmaceutical preparations containing urea derivatives

Publications (2)

Publication Number Publication Date
IL55774A0 IL55774A0 (en) 1978-12-17
IL55774A true IL55774A (en) 1982-04-30

Family

ID=27509239

Family Applications (1)

Application Number Title Priority Date Filing Date
IL55774A IL55774A (en) 1977-10-28 1978-10-20 Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture

Country Status (15)

Country Link
US (1) US4234736A (fr)
JP (1) JPS5473754A (fr)
AU (2) AU522796B2 (fr)
BE (1) BE871584A (fr)
BR (1) BR7807115A (fr)
CA (2) CA1138334A (fr)
DE (1) DE2846945A1 (fr)
DK (1) DK481778A (fr)
FR (1) FR2407205A1 (fr)
GB (2) GB2008101B (fr)
IL (1) IL55774A (fr)
IT (1) IT1100904B (fr)
NL (1) NL7810562A (fr)
NZ (1) NZ188720A (fr)
SE (2) SE433304B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine
FI801184A7 (fi) * 1979-04-24 1981-01-01 F Hoffmann La Roche & Co Menetelmä imidatsolidiini-johdannaisten valmistamiseksi.
EP0091596B1 (fr) * 1982-04-08 1991-09-11 Shell Internationale Researchmaatschappij B.V. Hydantoins, préparation et application
JP2791156B2 (ja) * 1988-08-23 1998-08-27 ザ ヌトラスウィート カンパニー 強力甘味料としての置換アリール尿素
FR2656302B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveau procede de preparation de l'anandron et derives de l'anandron.
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2671348B1 (fr) * 1991-01-09 1993-03-26 Roussel Uclaf Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
US5670641A (en) * 1995-06-02 1997-09-23 American Cyanamid Company 3-(3-aryloxyphenyl)-1-(substituted methyl)-S-triazine-2,4,6-oxo or thiotrione herbicidal agents
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7001911B2 (en) * 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
MXPA02012605A (es) 2000-06-28 2003-05-14 Squibb Bristol Myers Co Moduladores selectivos del receptor androgeno y metodo para su identificacion, dise°o y uso.
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
EP1854798A3 (fr) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Composés de succinimide hétérocyclique fondu et leurs analogies, modulateurs de la fonction de récepteur d'hormone nucléaire
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7087636B2 (en) 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
ATE502298T1 (de) * 2003-12-19 2011-04-15 Univ California Verfahren und materialien zur beurteilung von prostatakrebstherapien
NZ550102A (en) * 2004-02-24 2010-10-29 Univ California Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US7709517B2 (en) * 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
SI2656842T1 (sl) 2006-03-27 2016-10-28 The Regents Of The University Of California Modulator androgenih receptorjev za zdravljenje raka prostate in bolezni, povezanih z androgenimi receptorji
WO2007127010A2 (fr) 2006-03-29 2007-11-08 The Regents Of The University Of California Composés de diarylthiohydantoïne
EP2620432A3 (fr) 2007-10-26 2013-12-18 The Regents Of the University of California Composés de diarylhydantoïne
AU2011218173C1 (en) 2010-02-16 2015-04-16 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
NZ744456A (en) 2012-09-26 2019-09-27 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
PL2945628T3 (pl) 2013-01-15 2020-09-21 Aragon Pharmaceuticals, Inc. Modulator receptorów androgenowych w skojarzeniu z octanem abirateronu i prednizonem do leczenia nowotworu stercza
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
US10702508B2 (en) 2017-10-16 2020-07-07 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629779A (fr) *
US3134663A (en) * 1957-07-23 1964-05-26 Geigy Chem Corp Herbicidal composition and method employing hydantoins
GB997037A (en) 1962-03-19 1965-06-30 Ici Ltd New hydrantoin derivatives
IL31416A0 (en) 1968-02-19 1969-03-27 Bayer Ag 5-imino-2-oxo-imidazolidines,their preparation and use as herbicides
SE339690B (fr) * 1968-03-28 1971-10-18 Geigy Ag J R
DK123717B (da) * 1968-11-25 1972-07-24 Sumitomo Chemical Co 3-(3',5'-Dihalogenphenyl)-imidazolidin-2,4-dionderivater med mirobicid virkning.
US3676456A (en) * 1970-02-27 1972-07-11 Ciba Geigy Corp Derivatives of 3-aryl-5-alkylhydantoins
JPS5136332B1 (fr) * 1970-12-09 1976-10-07
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
IL45459A (en) 1973-09-03 1978-01-31 Ciba Geigy Ag 1-(dichlorofluoromethylthio)-3-phenyl-imidazolidine-2,4-dione derivatives their preparation and their use as bactericides and fungicides
FR2329276A1 (fr) 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant

Also Published As

Publication number Publication date
JPS5473754A (en) 1979-06-13
IT1100904B (it) 1985-09-28
CA1137091A (fr) 1982-12-07
CA1138334A (fr) 1982-12-28
BE871584A (fr) 1979-04-27
GB2008101A (en) 1979-05-31
GB2087870A (en) 1982-06-03
DE2846945A1 (de) 1979-05-03
NZ188720A (en) 1984-12-14
SE8202106L (sv) 1982-04-01
FR2407205B1 (fr) 1982-12-31
SE433304B (sv) 1984-05-21
GB2087870B (en) 1982-11-10
GB2008101B (en) 1982-09-08
AU4096278A (en) 1980-05-01
SE7811193L (sv) 1979-04-29
FR2407205A1 (fr) 1979-05-25
IL55774A0 (en) 1978-12-17
US4234736A (en) 1980-11-18
NL7810562A (nl) 1979-05-02
AU522796B2 (en) 1982-06-24
IT7829207A0 (it) 1978-10-27
BR7807115A (pt) 1979-05-15
DK481778A (da) 1979-04-29
AU8105182A (en) 1982-07-08
AU551161B2 (en) 1986-04-17

Similar Documents

Publication Publication Date Title
IL55774A0 (en) Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture
IL55351A0 (en) Novel nitroimidazoles,their manufacture and pharmaceutical compositions containing them
IL54842A (en) 1-piperidino-phthalazine derivatives,their preparation and pharmaceutical compositions containing them
IL56017A (en) 5-cyano-prostacyclin derivatives,their manufacture and pharmaceutical compositions containing them
IL55382A (en) Propenylamines,their production and pharmaceutical compositions containing them
IL55845A0 (en) Novel quinazoline derivatives, their preparation and pharmaceutical compositions containing them
IL59563A0 (en) Urea derivatives,their manufacture and pharmaceutical compositions containing them
IL55765A (en) Dehydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL56241A0 (en) New peptide derivatives, their manufacture and pharmaceutical compositions containing them
IL54535A0 (en) Novel -lactam derivatives, their preparation and pharmaceutical compositions containing them
IL54591A0 (en) Novel benzimidazole derivatives, their manufacture and pharmaceutical compositions containing them
IL55832A0 (en) Novel 2-imino-imidazilidine derivatives,their manufacture and pharmacheutical compositions containing them
IL53926A0 (en) New oxadiazolopyrimidine derivatives, their manufacture and pharmaceutical compositions containing them
IL53766A0 (en) 4-diphenylmethylene-1-hydroxybenzyl-piperidine derivatives, their preparation and pharmaceutical compositions containing them
IL55018A (en) Benzylpyrimidines,their manufacture and pharmaceutical compositions containing them
IL54105A (en) 2-acylamino-4-amino-5-benzylpyrimidine derivatives,their production and pharmaceutical compositions containing them
IL55857A0 (en) Novel quinazoline derivatives, their preparation and pharmaceutical compositions containing them
IL53925A0 (en) Novel oxadiazolopyrimidine derivatives, their manufacture and pahrmaceutical compositions containing them
IL54328A0 (en) Novel quinazoline derivatives, their manufacture and pharmaceutical compositions containing them
IL61040A0 (en) Pyridazopyridazine derivatives,their manufacture and pharmaceutical compositions containing them
IL53861A0 (en) Novel n-aralkylaniline derivatives, their preparation and pharmaceutical compositions containing them
IL55371A0 (en) Novel thiazine derivatives,their manufacture and pharmaceutical compositions containing them
IL54803A0 (en) Novel acyl derivatives, their manufacture and pharmaceutical compositions containing them
IL55095A0 (en) Novel piperidino-propanol derivatives,their preparation and pharmaceutical compositions containing them
IL55651A0 (en) Thienobenzazepine derivatives,their production and pharmaceutical compositions containing them